(Q37494500)

20 August 2017

title

Oncologic outcome after radical prostatectomy in men with PSA values above 20 ng/ml: a monocentric experience (English)

1 reference

20 August 2017

Olivier Cussenot

10

0 references

Morgan Rouprêt

11

object named as

Morgan Rouprêt

1 reference

Emmanuel Chartier-Kastler

20 August 2017

8

object named as

Emmanuel Chartier-Kastler

1 reference

20 August 2017

7

Marc-Olivier Bitker

1 reference

20 August 2017

4

Eva Comperat

1 reference

20 August 2017

Kien Nguyen

1

1 reference

20 August 2017

Stephanie Eltz

2

1 reference

20 August 2017

Sarah J Drouin

3

1 reference

20 August 2017

François Audenet

5

1 reference

20 August 2017

Raphaele Renard-Penna

6

1 reference

20 August 2017

François Richard

9

1 reference

20 August 2017

publication date

23 May 2009

1 reference

20 August 2017

published in

World Journal of Urology

1 reference

20 August 2017

volume

27

1 reference

20 August 2017

issue

5

1 reference

20 August 2017

page(s)

653-658

1 reference

The prostatic specific antigen era is alive and well: prostatic specific antigen and biochemical progression following radical prostatectomy

20 August 2017

cites work

1 reference

12 December 2020

Outcome of prostate cancer patients with initial PSA> or =20 ng/ml undergoing radical prostatectomy

1 reference

12 December 2020

Extraperitoneal standard laparoscopic radical prostatectomy

1 reference

12 December 2020

[High PSA and total prostatectomy: specific and overall 10-year survival]

1 reference

12 December 2020

Cancer control with radical prostatectomy alone in 1,000 consecutive patients

1 reference

12 December 2020

Mayo Clinic validation of the D'amico risk group classification for predicting survival following radical prostatectomy

1 reference

12 December 2020

The effect of prostate weight on the outcomes of laparoscopic radical prostatectomy

1 reference

12 December 2020

The role of radical prostatectomy in patients with clinically localized prostate cancer and a prostate-specific antigen level >20 ng/ml

1 reference

12 December 2020

Dynamic Contrast Enhanced, Pelvic Phased Array Magnetic Resonance Imaging of Localized Prostate Cancer for Predicting Tumor Volume: Correlation With Radical Prostatectomy Findings

1 reference

12 December 2020

Oncological control after radical prostatectomy in men with clinical T3 prostate cancer: a single-centre experience

1 reference

12 December 2020

Should patients with a pre-operative prostate-specific antigen greater than 15 ng/ml be offered radical prostatectomy?

1 reference

12 December 2020

Radical prostatectomy versus watchful waiting in early prostate cancer

1 reference

12 December 2020

Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy

1 reference

12 December 2020

Cancer statistics, 2008

1 reference

12 December 2020

Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update

1 reference

12 December 2020

Quality of life and satisfaction with outcome among prostate-cancer survivors

1 reference

12 December 2020

Impact of the percentage of positive prostate cores on prostate cancer-specific mortality for patients with low or favorable intermediate-risk disease

1 reference

12 December 2020

The role of radical prostatectomy in patients with pretreatment prostate-specific antigen > or = 40 ng/mL

1 reference

12 December 2020

Biochemical disease-free survival in patients with a high prostate-specific antigen level (20-100 ng/mL) and clinically localized prostate cancer after radical prostatectomy

1 reference

12 December 2020

Prostate cancer: accurate determination of extracapsular extension with high-spatial-resolution dynamic contrast-enhanced and T2-weighted MR imaging--initial results.

1 reference

12 December 2020

Use of nomograms to predict the risk of disease recurrence after definitive local therapy for prostate cancer

1 reference

12 December 2020

Prediction of pathological stage is inaccurate in men with PSA values above 20 ng/mL.

1 reference

12 December 2020

10.1007/S00345-009-0419-8

Identifiers

DOI

1 reference

20 August 2017

1 reference